Contact
Please use this form to send email to PR contact of this press release:
Kinnov Therapeutics Announces Positive Phase 2 Outcome: Key Milestone with Lead Drug KT-110 for Alcohol Use Disorder
TO:
Dr. Bill Mason
The Sage Group
+44 7785 950134